This year, Arvato Systems is supporting the CPHI Pharma Trend Report and contributing its technical expertise on the use of IT in the pharmaceutical sector and digital transformation. Stefan Moch, Vice President Health at Arvato Systems and an expert on the digitalization of the pharmaceutical industry, explains key IT trends for the sector in the report.
The team of Arvato System experts responsible for the pharmaceutical sector sees the trend topics of Data and Artificial Intelligence as the main focus for 2024. Both are topics that the IT service provider headquartered in Gütersloh has been working on intensively for many years. Above all, generative AI and the digitalization of the supply chain are of central importance. "At Arvato Systems, we understand the challenges facing the pharmaceutical industry and are committed to providing innovative solutions for an efficient and data-driven value chain," explains Stefan Moch.
In addition to generative AI and supply chain digitalization, the CPHI Pharma Trend Report 2024 is also dedicated to a number of other relevant topics. These include innovations in the context of pharmaceutical packaging, sophisticated quality management and the outsourcing of research and development. The future of B2B pharma marketing and the emerging markets in the Middle East and Africa are also highlighted.
Industry experts from various companies have contributed insights and opinions to this report. Arvato Systems' participation in the CPHI Pharma Trend Report 2024 underscores the company's commitment to the further development and digitalization of the pharmaceutical industry. With its established solutions such as Arvato CSDB, the IT service provider has made a name for itself in the industry and supports pharmaceutical companies in implementing regulatory requirements digitally and efficiently.
The team of Arvato System experts responsible for the pharmaceutical sector sees the trend topics of Data and Artificial Intelligence as the main focus for 2024. Both are topics that the IT service provider headquartered in Gütersloh has been working on intensively for many years. Above all, generative AI and the digitalization of the supply chain are of central importance. "At Arvato Systems, we understand the challenges facing the pharmaceutical industry and are committed to providing innovative solutions for an efficient and data-driven value chain," explains Stefan Moch.
In addition to generative AI and supply chain digitalization, the CPHI Pharma Trend Report 2024 is also dedicated to a number of other relevant topics. These include innovations in the context of pharmaceutical packaging, sophisticated quality management and the outsourcing of research and development. The future of B2B pharma marketing and the emerging markets in the Middle East and Africa are also highlighted.
Industry experts from various companies have contributed insights and opinions to this report. Arvato Systems' participation in the CPHI Pharma Trend Report 2024 underscores the company's commitment to the further development and digitalization of the pharmaceutical industry. With its established solutions such as Arvato CSDB, the IT service provider has made a name for itself in the industry and supports pharmaceutical companies in implementing regulatory requirements digitally and efficiently.
